JAMES HOLBROOK: Open Payments
NPI 1235551680 · STANTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 19 payments from 8 companies in 2025. Trend: 2023 $225 · 2024 $320 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| Lilly USA, LLC | 4 | $80 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Abbott Laboratories | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: FARXIGA, JARDIANCE, TRELEGY ELLIPTA, AIRSUPRA, Cologuard Collection Kit, FREESTYLE LIBRE 3, Wegovy, REXULTI.
Industry payments across KY — which companies pay providers there.
